Warren Hoeffler

Background

About Warren Hoeffler

Hof Therapeutics provides a new pathway to medical innovation. Our core technologies are: cryotronic freezing to maintain cell viability in tissues and small organisms, spontaneous cell sorting to create 3-D tissues and organs outside of the body, and a unique fibrosis assay to allow efficient screening of anti-fibrotic compounds; we also offer lead compounds- reinterpreted gene control signaling for obtaining predictive profiles for genes of interest and blood vessel (microvasculature) formation in tissues maintained outside the body as a tool for accelerating wound healing and successful grafting of lab synthesized organs. We partner with other businesses to provide solutions when they are faced with difficulty using conventional technologies. Our engineering perspective in biology enables us to focus on the approach most likely to solve the problem at hand. Our vast experience with cell culturing, and our profile of unique core technologies allows us to develop innovative products and solutions. Our more advanced 3-D cell assembled assays, such as VeriSkin, empower your product development with superior cell based assays. Our cryotronic freezing enables viable freezing of complex biological material which has never before been frozen successfully. There are broad applications for these in-demand technologies. Invite us to present our platforms at your organization today.